Article · Wikipedia archive · Last revised Jun 23, 2026

Atrophin 1

Atrophin-1 is a protein that in humans is encoded by the ATN1 gene. The encoded protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. The function of Atrophin-1 has not yet been determined. There is evidence provided by studies of Atrophin-1 in animals to suggest it acts as a transcriptional co-repressor. Atrophin-1 can be found in the nuclear and cytoplasmic compartments of neurons. It is expressed in nervous tissue.

Last revised
Jun 23, 2026
Read time
≈ 8 min
Length
1,855 w
Citations
34
Source
ATN1
Identifiers
AliasesATN1, B37, D12S755E, DRPLA, HRS, NOD, atrophin 1, CHEDDA
External IDsOMIM: 607462; MGI: 104725; HomoloGene: 1461; GeneCards: ATN1; OMA:ATN1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001940
NM_001007026

NM_007881

RefSeq (protein)

NP_001007027
NP_001931

NP_031907

Location (UCSC)Chr 12: 6.92 – 6.94 MbChr 6: 124.72 – 124.73 Mb
PubMed search34
Wikidata
View/Edit HumanView/Edit Mouse

Atrophin-1 is a protein that in humans is encoded by the ATN1 gene.5 The encoded protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat.6 The function of Atrophin-1 has not yet been determined.7 There is evidence provided by studies of Atrophin-1 in animals to suggest it acts as a transcriptional co-repressor.7 Atrophin-1 can be found in the nuclear and cytoplasmic compartments of neurons.7 It is expressed in nervous tissue.8

Function

The function of Atrophin-1 has not been defined yet. It is widely hypothesized that Atrophin-1 functions as a transcriptional co-repressor.9 A transcriptional co-repressor is a protein that indirectly suppresses the activity of specific genes by interacting with DNA-binding proteins.9

Clinical significance

The ATN1 gene has a segment of DNA called the CAG trinucleotide repeat.9 It is made up of cytosine, adenine, and guanine.9 The number of CAG repeats in the ATN1 gene in a healthy person will range from six to thirty-five repeats.9 CAG repeats that exceed thirty-five can cause a gain-of-function mutation in ATN1.10 Studies have supported the idea that mutated Atrophin-1 gathers in neurons and disrupts cell function.11 The sequence of the ATN1 gene contains a nuclear localizing signal (NLS) and a nuclear export signal (NES).11 It has been shown that a mutation of the NES in ATN1 can change where ATN1 localizes, and can cause aggregation to occur in the nucleus.11 This can lead to an increase in cellular toxicity.11

Mutations in ATN1 are associated with a form of trinucleotide repeat disorder known as "dentatorubral-pallidoluysian atrophy" or "dentatorubropallidoluysian atrophy". Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia.5 The disorder is related to the expansion of a trinucleotide repeat within this gene.5 In patients with DRPLA, truncated ATN1 has been observed forming intranuclear aggregates that cause cell death.11 The symptoms of this disorder can be credited to the significant reduction of brain and spinal tissue observed in those afflicted with DRPLA.12 There are both juvenile-onset and late adult-onset variants of DRPLA, which show differing degrees of severity of specific symptoms.12

Interactions

ATN1 has been shown to interact with:

References

References

  1. GRCh38: Ensembl release 89: ENSG00000111676Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000004263Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "ATN1 atrophin 1 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-03-12.
  6. "Entrez Gene: ATN1 atrophin 1".
  7. Wood JD, Nucifora FC, Duan K, Zhang C, Wang J, Kim Y, Schilling G, Sacchi N, Liu JM, Ross CA (September 2000). "Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription". The Journal of Cell Biology. 150 (5): 939–48. doi:10.1083/jcb.150.5.939. PMC 2175251. PMID 10973986.
  8. Shen Y, Peterson AS (February 2009). "Atrophins' emerging roles in development and neurodegenerative disease". Cellular and Molecular Life Sciences. 66 (3): 437–46. doi:10.1007/s00018-008-8403-9. PMC 11131516. PMID 18953689. S2CID 11380927.
  9. "ATN1 gene". Genetics Home Reference. Retrieved 2017-02-21.
  10. Shen Y, Lee G, Choe Y, Zoltewicz JS, Peterson AS (February 2007). "Functional architecture of atrophins". The Journal of Biological Chemistry. 282 (7): 5037–44. doi:10.1074/jbc.M610274200. PMID 17150957.
  11. Suzuki Y, Yazawa I (April 2011). "Pathological accumulation of atrophin-1 in dentatorubralpallidoluysian atrophy". International Journal of Clinical and Experimental Pathology. 4 (4): 378–84. PMC 3093063. PMID 21577324.
  12. "Dentatorubral-Pallidoluysian Atrophy, DRPLA". themedicalbiochemistrypage.org. Retrieved 2017-02-21.
  13. Okamura-Oho Y, Miyashita T, Ohmi K, Yamada M (June 1999). "Dentatorubral-pallidoluysian atrophy protein interacts through a proline-rich region near polyglutamine with the SH3 domain of an insulin receptor tyrosine kinase substrate". Human Molecular Genetics. 8 (6): 947–57. doi:10.1093/hmg/8.6.947. PMID 10332026.
  14. Wood JD, Yuan J, Margolis RL, Colomer V, Duan K, Kushi J, Kaminsky Z, Kleiderlein JJ, Sharp AH, Ross CA (June 1998). "Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins". Molecular and Cellular Neurosciences. 11 (3): 149–60. doi:10.1006/mcne.1998.0677. PMID 9647693. S2CID 20003277.
  15. Yanagisawa H, Bundo M, Miyashita T, Okamura-Oho Y, Tadokoro K, Tokunaga K, Yamada M (May 2000). "Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine". Human Molecular Genetics. 9 (9): 1433–42. doi:10.1093/hmg/9.9.1433. PMID 10814707.
Further reading

Further reading

External links